DE60217932D1 - Kristalline Zusammensetzung enthaltend Escitalopram - Google Patents

Kristalline Zusammensetzung enthaltend Escitalopram

Info

Publication number: DE60217932D1
Authority: DE; Germany
Prior art keywords: composition containing; crystalline composition; containing escitalopram; escitalopram; crystalline
Prior art date: 2001-07-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Revoked

Application number

DE60217932T

Other languages

English (en)

Other versions

DE60217932T2 (de

Inventor

Volsgaard Christensen

Ken Liljegren

Onne Elema

Lene Andresen

Shashank Mahashabde

Sebastian P Assenza

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

H Lundbeck AS

Original Assignee

H Lundbeck AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-31

Filing date

2002-07-25

Publication date

2007-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60217932(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-25 Application filed by H Lundbeck AS filed Critical H Lundbeck AS

2007-03-15 Publication of DE60217932D1 publication Critical patent/DE60217932D1/de

2007-08-30 Application granted granted Critical

2007-08-30 Publication of DE60217932T2 publication Critical patent/DE60217932T2/de

2022-07-26 Anticipated expiration legal-status Critical

Status Revoked legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cephalosporin Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DE60217932T 2001-07-31 2002-07-25 Kristalline Zusammensetzung enthaltend Escitalopram Revoked DE60217932T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101164		2001-07-31
DK200101164		2001-07-31

Publications (2)

Publication Number	Publication Date
DE60217932D1 true DE60217932D1 (de)	2007-03-15
DE60217932T2 DE60217932T2 (de)	2007-08-30

Family

ID=8160647

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60217932T Revoked DE60217932T2 (de)	2001-07-31	2002-07-25	Kristalline Zusammensetzung enthaltend Escitalopram
DE60202615T Revoked DE60202615T2 (de)	2001-07-31	2002-07-25	Kristalline zusammensetzung mit escitalopram

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60202615T Revoked DE60202615T2 (de)	2001-07-31	2002-07-25	Kristalline zusammensetzung mit escitalopram

Country Status (40)

Country	Link
US (3)	US6916941B2 (de)
EP (2)	EP1414435B1 (de)
JP (4)	JP2005525993A (de)
KR (1)	KR20040028947A (de)
CN (2)	CN1660074A (de)
AR (1)	AR034898A1 (de)
AT (2)	ATE352546T1 (de)
AU (1)	AU2002355624B2 (de)
BG (1)	BG108571A (de)
BR (1)	BR0206164A (de)
CA (1)	CA2451915C (de)
CO (1)	CO5560540A2 (de)
CY (1)	CY1106413T1 (de)
DE (2)	DE60217932T2 (de)
DK (2)	DK1414435T3 (de)
EA (1)	EA006213B1 (de)
EG (1)	EG24206A (de)
ES (2)	ES2280892T3 (de)
HK (1)	HK1070000A1 (de)
HR (2)	HRP20031073A2 (de)
HU (1)	HUP0401946A2 (de)
IL (2)	IL159326A0 (de)
IS (1)	IS7077A (de)
MA (1)	MA27349A1 (de)
ME (1)	MEP2108A (de)
MX (1)	MXPA04000849A (de)
MY (1)	MY126238A (de)
NO (1)	NO328346B1 (de)
NZ (1)	NZ530157A (de)
PE (1)	PE20030304A1 (de)
PL (1)	PL366995A1 (de)
PT (2)	PT1522539E (de)
RS (1)	RS8304A (de)
SI (1)	SI1414435T1 (de)
TN (1)	TNSN04021A1 (de)
TR (1)	TR200400189T2 (de)
UA (1)	UA79930C2 (de)
UY (1)	UY27404A1 (de)
WO (1)	WO2003011278A1 (de)
ZA (1)	ZA200309684B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3798940B2 (ja)	1999-04-14	2006-07-19	ハー・ルンドベック・アクチエゼルスカベット	シタロプラムの製造方法
US20030109577A1 (en) *	2000-10-27	2003-06-12	Ken Liljegren	Pharmaceutical composition containing citalopram
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
MEP2108A (xx) *	2001-07-31	2010-02-10	Lundbeck & Co As H	Kristalni sastav koji sadrži escitalopram
PE20040991A1 (es)	2002-08-12	2004-12-27	Lundbeck & Co As H	Separacion de intermediarios para la preparacion de escitalopram
TR200504022T1 (tr) *	2003-03-24	2006-08-21	Hetero Drugs Limited	(S)-sitalopram oksalatın yeni sıvı kristal formları.
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
TWI339651B (en) *	2004-02-12	2011-04-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
EA200601641A1 (ru) *	2004-03-05	2006-12-29	Х. Лундбекк А/С	Кристаллическая композиция, содержащая оксалат эсциталопрама
US20050196453A1 (en)	2004-03-05	2005-09-08	H. Lundbeck A/S	Crystalline composition containing escitalopram
WO2006123243A2 (en) *	2005-05-20	2006-11-23	Aurobindo Pharma Limited	Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) *	2005-06-22	2011-09-01	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US20070098804A1 (en) *	2005-08-29	2007-05-03	Judith Aronhime	Solid particulate tadalafil having a bimodal particle size distribution
CA2625835A1 (en)	2005-10-14	2007-05-10	Forest Laboratories, Inc.	Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en)	2006-01-23	2006-03-01	Sandoz Ag	Asymmetric synthesis
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
EP2086509A1 (de) *	2006-10-20	2009-08-12	Ratiopharm GmbH	Escitalopram und dieses enthaltende feste pharmazeutische zusammensetzung
US20090048336A1 (en) *	2007-08-17	2009-02-19	Naveen Kumar Kolla	Escitalopram oxalate powders
WO2009135646A2 (en) *	2008-05-05	2009-11-12	Farmaprojects, Sa	Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (de)	2008-05-07	2009-11-11	Hexal Ag	Granulat mit Escitalopramoxalat
GR20080100696A (el)	2008-10-23	2010-05-13	Genepharm �.�.	Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) *	2012-01-30	2013-07-31	Carthesia Sas	Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) *	2012-01-30	2013-07-31	Carthesia S A S	Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
CN106397248A (zh) *	2015-08-03	2017-02-15	深圳信立泰药业股份有限公司	一种lcz696结晶粉末及其制备方法
JP2018016569A (ja) *	2016-07-26	2018-02-01	株式会社トクヤマ	（１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) *	2017-04-10	2018-11-14	東和薬品株式会社	エスシタロプラム医薬組成物
CN107441052A (zh) *	2017-06-21	2017-12-08	山东京卫制药有限公司	一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) *	2017-11-01	2020-03-16	한국화학연구원	에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja)	2020-06-22	2024-03-21	東和薬品株式会社	エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143702A (de)	1965-03-18
GB1358915A (en)	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en)	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
ES2058061T3 (es)	1985-10-25	1994-11-01	Beecham Group Plc	Derivado de piperidina, su preparacion y su uso como medicamento.
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en)	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
GB9325644D0 (en)	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5683720A (en)	1994-10-28	1997-11-04	Fuisz Technologies Ltd.	Liquiflash particles and method of making same
EP0714663A3 (de)	1994-11-28	1997-01-15	Lilly Co Eli	Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
AU5966196A (en)	1995-06-08	1997-01-09	Eli Lilly And Company	Methods of treating cold and allergic rhinitis
CZ291440B6 (cs)	1997-07-08	2003-03-12	H. Lundbeck A/S	Způsob výroby citalopramu
GB9714841D0 (en)	1997-07-14	1997-09-17	Smithkline Beecham Plc	Treatment method
US5980941A (en)	1997-08-20	1999-11-09	Fuisz Technologies Ltd.	Self-binding shearform compositions
US5869098A (en)	1997-08-20	1999-02-09	Fuisz Technologies Ltd.	Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5840334A (en)	1997-08-20	1998-11-24	Fuisz Technologies Ltd.	Self-binding shearform compositions
UA62985C2 (en)	1997-11-10	2004-01-15	Lunnbeck As H	A method for the preparation of citalopram
CN1286687A (zh) *	1997-11-11	2001-03-07	H·隆德贝克有限公司	制备西酞普兰的方法
SK285719B6 (sk)	1998-10-20	2007-07-06	H. Lundbeck A/S	Spôsob prípravy citalopramu a medziprodukty
TWI230618B (en) *	1998-12-15	2005-04-11	Gilead Sciences Inc	Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
JP3798940B2 (ja)	1999-04-14	2006-07-19	ハー・ルンドベック・アクチエゼルスカベット	シタロプラムの製造方法
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
WO2001022941A1 (en) *	1999-09-28	2001-04-05	H. Lundbeck A/S	Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en)	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
MEP2108A (xx)	2001-07-31	2010-02-10	Lundbeck & Co As H	Kristalni sastav koji sadrži escitalopram

2002
- 2002-07-25 ME MEP-21/08A patent/MEP2108A/xx unknown
- 2002-07-25 RS YU8304A patent/RS8304A/sr unknown
- 2002-07-25 IL IL15932602A patent/IL159326A0/xx unknown
- 2002-07-25 HU HU0401946A patent/HUP0401946A2/hu unknown
- 2002-07-25 ZA ZA200309684A patent/ZA200309684B/xx unknown
- 2002-07-25 EP EP02750846A patent/EP1414435B1/de not_active Revoked
- 2002-07-25 CN CN2004100941660A patent/CN1660074A/zh active Pending
- 2002-07-25 DE DE60217932T patent/DE60217932T2/de not_active Revoked
- 2002-07-25 AR ARP020102808A patent/AR034898A1/es unknown
- 2002-07-25 KR KR10-2004-7001140A patent/KR20040028947A/ko not_active Application Discontinuation
- 2002-07-25 PL PL02366995A patent/PL366995A1/xx unknown
- 2002-07-25 PT PT04029282T patent/PT1522539E/pt unknown
- 2002-07-25 UA UA20031212659A patent/UA79930C2/uk unknown
- 2002-07-25 MX MXPA04000849A patent/MXPA04000849A/es active IP Right Grant
- 2002-07-25 TR TR2004/00189T patent/TR200400189T2/xx unknown
- 2002-07-25 AT AT04029282T patent/ATE352546T1/de not_active IP Right Cessation
- 2002-07-25 DE DE60202615T patent/DE60202615T2/de not_active Revoked
- 2002-07-25 JP JP2003516508A patent/JP2005525993A/ja active Pending
- 2002-07-25 DK DK02750846T patent/DK1414435T3/da active
- 2002-07-25 ES ES04029282T patent/ES2280892T3/es not_active Expired - Lifetime
- 2002-07-25 EP EP04029282A patent/EP1522539B1/de not_active Revoked
- 2002-07-25 EA EA200400243A patent/EA006213B1/ru not_active IP Right Cessation
- 2002-07-25 BR BR0206164-3A patent/BR0206164A/pt not_active Application Discontinuation
- 2002-07-25 ES ES02750846T patent/ES2233842T3/es not_active Expired - Lifetime
- 2002-07-25 DK DK04029282T patent/DK1522539T3/da active
- 2002-07-25 WO PCT/DK2002/000513 patent/WO2003011278A1/en active Application Filing
- 2002-07-25 SI SI200230091T patent/SI1414435T1/xx unknown
- 2002-07-25 AU AU2002355624A patent/AU2002355624B2/en not_active Ceased
- 2002-07-25 CA CA2451915A patent/CA2451915C/en not_active Expired - Fee Related
- 2002-07-25 PT PT02750846T patent/PT1414435E/pt unknown
- 2002-07-25 NZ NZ530157A patent/NZ530157A/en not_active IP Right Cessation
- 2002-07-25 CN CNB028150317A patent/CN1311819C/zh not_active Expired - Lifetime
- 2002-07-25 AT AT02750846T patent/ATE286730T1/de active
- 2002-07-26 PE PE2002000675A patent/PE20030304A1/es not_active Application Discontinuation
- 2002-07-28 EG EG2002070849A patent/EG24206A/xx active
- 2002-07-30 UY UY27404A patent/UY27404A1/es not_active Application Discontinuation
- 2002-07-30 MY MYPI20022871A patent/MY126238A/en unknown
2003
- 2003-03-31 US US10/403,453 patent/US6916941B2/en not_active Expired - Lifetime
- 2003-12-11 IL IL159326A patent/IL159326A/en unknown
- 2003-12-15 IS IS7077A patent/IS7077A/is unknown
- 2003-12-23 HR HR20031073A patent/HRP20031073A2/xx not_active Application Discontinuation
2004
- 2004-01-27 TN TNP2004000021A patent/TNSN04021A1/en unknown
- 2004-01-28 NO NO20040380A patent/NO328346B1/no not_active IP Right Cessation
- 2004-02-04 MA MA27512A patent/MA27349A1/fr unknown
- 2004-02-09 BG BG108571A patent/BG108571A/xx unknown
- 2004-02-25 CO CO04016758A patent/CO5560540A2/es not_active Application Discontinuation
2005
- 2005-02-07 US US11/053,641 patent/US7420069B2/en not_active Expired - Lifetime
- 2005-04-04 HK HK05102804A patent/HK1070000A1/xx not_active IP Right Cessation
2007
- 2007-03-23 CY CY20071100411T patent/CY1106413T1/el unknown
2008
- 2008-08-22 HR HR20080410A patent/HRPK20080410B3/xx not_active IP Right Cessation
- 2008-08-22 US US12/196,812 patent/US20080305164A1/en not_active Abandoned
2010
- 2010-03-16 JP JP2010059368A patent/JP4971477B2/ja not_active Expired - Lifetime
2011
- 2011-05-30 JP JP2011120483A patent/JP5192568B2/ja not_active Expired - Lifetime
2012
- 2012-07-26 JP JP2012166170A patent/JP5719811B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
RS8304A (en)	2006-12-15
KR20040028947A (ko)	2004-04-03
MY126238A (en)	2006-09-29
BR0206164A (pt)	2003-10-28
US20080305164A1 (en)	2008-12-11
TNSN04021A1 (en)	2006-06-01
US6916941B2 (en)	2005-07-12
BG108571A (en)	2005-02-28
PE20030304A1 (es)	2003-03-27
CO5560540A2 (es)	2005-09-30
EP1414435B1 (de)	2005-01-12
DK1414435T3 (da)	2005-05-09
JP2005525993A (ja)	2005-09-02
HRP20080410A2 (en)	2008-10-31
IS7077A (is)	2003-12-15
EA200400243A1 (ru)	2004-06-24
US20030212128A1 (en)	2003-11-13
NZ530157A (en)	2007-06-29
HUP0401946A2 (hu)	2005-01-28
EP1522539A1 (de)	2005-04-13
ES2233842T3 (es)	2005-06-16
PT1522539E (pt)	2007-03-30
DE60202615T2 (de)	2006-01-12
NO328346B1 (no)	2010-02-01
CN1660074A (zh)	2005-08-31
US20050147674A1 (en)	2005-07-07
AU2002355624B2 (en)	2006-02-02
JP2011195591A (ja)	2011-10-06
ATE352546T1 (de)	2007-02-15
EG24206A (en)	2008-10-21
NO20040380L (no)	2004-01-28
HK1070000A1 (en)	2005-06-10
JP4971477B2 (ja)	2012-07-11
JP5192568B2 (ja)	2013-05-08
PT1414435E (pt)	2005-05-31
CY1106413T1 (el)	2011-10-12
PL366995A1 (en)	2005-02-07
ATE286730T1 (de)	2005-01-15
JP2012211186A (ja)	2012-11-01
JP5719811B2 (ja)	2015-05-20
WO2003011278A1 (en)	2003-02-13
JP2010150283A (ja)	2010-07-08
EP1414435A1 (de)	2004-05-06
TR200400189T2 (tr)	2004-12-21
US7420069B2 (en)	2008-09-02
ZA200309684B (en)	2004-12-22
DE60202615D1 (de)	2005-02-17
IL159326A (en)	2010-05-31
CA2451915C (en)	2010-09-21
IL159326A0 (en)	2004-06-01
EP1522539B1 (de)	2007-01-24
DE60217932T2 (de)	2007-08-30
ES2280892T3 (es)	2007-09-16
HRP20031073A2 (en)	2004-04-30
UA79930C2 (en)	2007-08-10
MXPA04000849A (es)	2004-05-14
AR034898A1 (es)	2004-03-24
MA27349A1 (fr)	2005-06-01
SI1414435T1 (en)	2005-06-30
CN1536997A (zh)	2004-10-13
EA006213B1 (ru)	2005-10-27
MEP2108A (xx)	2010-02-10
CN1311819C (zh)	2007-04-25
CA2451915A1 (en)	2003-02-13
DK1522539T3 (da)	2007-05-07
UY27404A1 (es)	2003-02-28
HRPK20080410B3 (en)	2009-09-30

Publication	Publication Date	Title
ATE352546T1 (de)	2007-02-15	Kristalline zusammensetzung enthaltend escitalopram
DK1451192T3 (da)	2011-04-04	Ny krystallinsk forbindelse
IS6915A (is)	2003-08-15	Lyfjablanda
BR0210619A (pt)	2006-05-23	composição
IS7081A (is)	2003-12-16	Lyfjablanda
DE60208476D1 (de)	2006-03-30	Blaulumineszierende Tintenzusammensetzung
ITTO20020747A0 (it)	2002-08-23	Composizione
DE60107312D1 (de)	2004-12-30	Feste Zusammensetzung
NO20033073L (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
ITTO20020745A0 (it)	2002-08-23	Composizione
ATE271600T1 (de)	2004-08-15	Feste zusammensetzung
FI20010068A0 (fi)	2001-01-12	Parannettu kiinnikekokoonpano
SE0100298D0 (sv)	2001-02-01	Composition
ITTO20020746A0 (it)	2002-08-23	Composizione
SE0101203D0 (sv)	2001-04-03	New composition
SE0101788D0 (sv)	2001-05-21	New composition
SE0104473D0 (sv)	2001-12-18	Novel Compounds
SE0102618D0 (sv)	2001-07-25	Novel compounds
SE0103820D0 (sv)	2001-11-15	Novel compounds
SE0103271D0 (sv)	2001-09-28	Novel compounds
SE0104472D0 (sv)	2001-12-14	Novel Compounds
SE0100641D0 (sv)	2001-02-26	Novel compounds
SE0100966D0 (sv)	2001-03-19	Novel compounds
SE0101321D0 (sv)	2001-04-12	Novel compounds
SE0102807D0 (sv)	2001-08-22	Novel compounds

Legal Events

Date	Code	Title	Description
2007-12-20	8363	Opposition against the patent
2011-03-24	8331	Complete revocation